Synthesis of Cis-Diammine (1,1-cyclobutane dicarboxylate) Platinum(II)

Document Type : Research Note


School of Chemistry, University College of Science, University of Tehran, Tehran, I.R. IRAN


Platinum-based anticancer drugs are chemotherapeutic agents to treat cancer. Carboplatin (cis diammine cyclobutane dicarboxylate platinum (II)) is a second generation drug that has less toxic than cisplatin, allowing for high dosages. In the first stage, 1,3-Cyclobutane dicarboxylic acid, a key intermediate for the preparation of carboplatin, have been synthesized in good yields using different methodology to achieve high purity then carboplatin was synthesized from the reaction of the prepared ligand with cisplatin. Purity of prepared carboplatin was confirmed by High-Performance Liquid Chro­matography (HPLC). Platinum(II) complex carboplatin,have been characterized with  1H and 13C nuclear magnetic resonance spectra and infrared spectroscopy.


Main Subjects

[1] Morris M., Eifel P.J., Lu J., Grigsby P.W., Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer, N. Engl. J. Med., 340: 1137-1143(1999).
[3] Loehrer P.J., Einhorn L.H., Cisplatin., Ann. Itern. Med., 100: 7 04-713(1984).
[4] Wong E., Giandomenico C.M.,Current Status of Platinum-Based Antitumor Drugs, Chem. Rev., 99: 2451-2466 (1999).
[5] Kidani Y., Inagaki K., Iigo M., Hoshi A., Kuretani K., Antitumor Activity of 1,2-Diaminocyclohexaneplatinum Complexes Against Sarcoma-180 Ascites Form, J. Med. Chem., 21: 1315-1318(1978).
[7] Kelland L., The Resurgence of Platinum-Based Cancer Chemotherapy, Nat. Rev. Cancer., 7: 573-584(2007).
[8] Wheate N.J., Walker S.., Craiga G.E., Ouna R., The Status of Platinum Anticancer Drugs in the Clinic and in Clinical Trials, Dalton Trans., 39 :8113-8127 (2010).
[12] Ibrahim A., Hirschfeld S., Cohen M.H., Griebel D.J., Williams G.A., Pazdur R., FDA Drug Approval Summaries: Oxaliplatin, Oncologist, 9: 8-12(2004).
[13] Raymond E., Chaney S.G., Taamma A., Cvitkovic E., Oxaliplatin: A Review of Preclinical and Clinical Studies, Ann. Oncol., 9:1053-1071(1998).